Jing, W., Gershan, J. A., & Johnson, B. D. (2009). Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory. American Society of Hematology.
Chicago Style aipamenaJing, Weiqing, Jill A. Gershan, and Bryon D. Johnson. Depletion of CD4 T Cells Enhances Immunotherapy for Neuroblastoma After Syngeneic HSCT but Compromises Development of Antitumor Immune Memory. American Society of Hematology, 2009.
MLA aipamenaJing, Weiqing, Jill A. Gershan, and Bryon D. Johnson. Depletion of CD4 T Cells Enhances Immunotherapy for Neuroblastoma After Syngeneic HSCT but Compromises Development of Antitumor Immune Memory. American Society of Hematology, 2009.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.